This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name : 
Invitrogen
other brands : 
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type : 
antibody
product name : 
C22orf36 Polyclonal Antibody
catalog : 
PA5-51716
quantity : 
100 uL
price : 
US 474.00
clonality : 
polyclonal
host : 
domestic rabbit
conjugate : 
nonconjugated
reactivity : 
human
application : 
immunohistochemistry, immunohistochemistry - paraffin section
product information
Product Type : 
Antibody
Product Name : 
C22orf36 Polyclonal Antibody
Catalog # : 
PA5-51716
Quantity : 
100 uL
Price : 
US 474.00
Clonality : 
Polyclonal
Purity : 
Antigen affinity chromatography
Host : 
Rabbit
Reactivity : 
Human
Applications : 
Immunohistochemistry (Paraffin): 1:20-1:50
Species : 
Human
Isotype : 
IgG
Storage : 
Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.
Description : 
The function of C22orf36 remains unknown.
Immunogen : 
Recombinant protein corresponding to Human C22orf36. Recombinant protein control fragment (Product # RP-91396 ).
Format : 
Liquid
Applications w/Dilutions : 
Immunohistochemistry (Paraffin): 1:20-1:50
Aliases : 
AI646023; C22orf36; Fam211b; family with sequence similarity 211, member B; leucine rich repeat containing 75B; leucine-rich repeat-containing protein 75B; leucine-rich repeat-containing protein C22orf36; leucine-rich repeat-containing protein C22orf36 homolog; leucine-rich repeat-containing protein FAM211B; LRRC75B
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments
